Sign In
NASDAQ:EDAP
EDAP TMS S.A. Stock News
$2.29
+0.0400 (+1.78%)
At Close: Mar 17, 2025
EDAP to Announce Fourth Quarter and Full Year 2024 Financial Results on March 27, 2025
07:00am, Thursday, 06'th Mar 2025
Company to host conference call and webcast on Thursday, March 27 th at 8:30am EDT AUSTIN, Texas, March 6, 2025 -- EDAP TMS SA (Nasdaq: EDAP) (“the Company”), the global leader in robotic energy-b
EDAP Appoints Glen French to Board of Directors
07:00am, Monday, 03'rd Mar 2025
PDF Version LYON, France, March 3, 2025 -- EDAP TMS SA (Nasdaq: EDAP) (“the Company” or “EDAP”), the global leader in robotic energy-based therapies, today announced the appointment of Glen Fr
Cortechs.ai and EDAP Announce World's First OnQ™ Prostate-Assisted Focal One® Robotic HIFU Procedure at UCSF Prostate Cancer Center
08:00am, Thursday, 06'th Feb 2025
San Diego, CA and Austin, Texas, February 6, 2025 - Cortechs.ai, an emerging leader in novel imaging solutions for prostate cancer care, and EDAP TMS SA (Nasdaq: EDAP), the global leader in robotic en
EDAP Announces Preliminary Record Fourth Quarter Focal One® System Sales and Record U.S. Procedures
07:00am, Monday, 13'th Jan 2025
Company Reports Preliminary Worldwide Record Fourth Quarter Sales of 11 Focal One Systems Record U.S. Fourth Quarter Focal One System Sales Record Number of U.S. Focal One Procedures, with Year-Over
EDAP Appoints Joshua H. Levine to Board of Directors
07:00am, Friday, 10'th Jan 2025
PDF Version
EDAP Announces First Pancreatic Cancer Patient Treated with Proprietary HIFU Technology
07:00am, Wednesday, 08'th Jan 2025
AUSTIN, Texas, January 8, 2025 - EDAP TMS SA (Nasdaq: EDAP), the global leader in robotic energy-based therapies, today announced that the first patient has been treated in a phase I/II PULS Trial spo
HIFI Study is the largest (N = 3,328) prospective, comparative, multi-center clinical study ever conducted comparing prostate cancer treatments Positive study results are expected to drive further ado
Treatment with robotic HIFU showed reduction in moderate and severe post-operative complications and reduced hospital stay compared to surgery LYON, France, November 19, 2024 - EDAP TMS SA (Nasdaq: ED
EDAP TMS S.A. (EDAP) Q3 2024 Earnings Call Transcript
09:16pm, Friday, 08'th Nov 2024
EDAP TMS S.A. (NASDAQ:EDAP ) Q3 2024 Earnings Conference Call November 7, 2024 8:30 AM ET Company Participants John Fraunces - LifeSci Advisors Ryan Rhodes - Chief Executive Officer Ken Mobeck - Chief
EDAP to Announce Third Quarter 2024 Financial Results on November 7, 2024
08:00am, Thursday, 24'th Oct 2024
Company to host conference call and webcast on Thursday, November 7 th at 8:30am EDT LYON, France, October 24, 2024 -- EDAP TMS SA (Nasdaq: EDAP) (“the Company”), the global leader in robotic ener
EDAP's Avenda Deal for AI-Assisted Cancer Care Likely to Drive Stock
10:21am, Monday, 23'rd Sep 2024
When combined with EDAP's Focal One platform, Avenda's Unfold AI enables more accurate and patient-specific treatment options.
EDAP and Avenda Health Launch World's First AI-Assisted Focal One® Robotic HIFU Procedures
08:00am, Thursday, 19'th Sep 2024
First Unfold AI ® -Assisted Focal One procedures successfully performed at the UCLA School of Medicine FDA-cleared Unfold AI enables urologists to provide tailored, patient-specific Robotic HIFU abla
EDAP to Participate in the H.C. Wainwright 26th Annual Global Investment Conference
08:00am, Thursday, 29'th Aug 2024
LYON, France, August 29, 2024 - EDAP TMS SA (Nasdaq: EDAP), the global leader in robotic energy-based therapies, announced that Ryan Rhodes, Chief Executive Officer, is scheduled to participate in a f
EDAP TMS S.A. (EDAP) Q2 2024 Earnings Call Transcript
11:30am, Wednesday, 28'th Aug 2024
EDAP TMS S.A. (NASDAQ:EDAP ) Q2 2024 Results Conference Call August 28, 2024 8:30 AM ET Company Participants John Fraunces - LifeSci Advisors Ryan Rhodes - Chief Executive Officer Ken Mobeck - Chief F
EDAP Reports Second Quarter 2024 Financial Results
07:00am, Wednesday, 28'th Aug 2024
Record Q2 2024 total worldwide revenue of EUR 15.8 million (USD 17.0 million) increased 10.6% over Q2 2023 Record first half 2024 total worldwide revenue of EUR 30.7 million (USD 33.1 million) increas
